Showing results (381-390 of 425) with videos related to
Sort By:
Pageof 43
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.NPJ Breast Cancer|January 3, 2024
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancerJennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, et al.Journal of the American College of Surgeons|May 17, 2023
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical TrialAnna Weiss, Tianyu Li, Neelam V Desai, et al.NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple MyelomaGheath Alatrash, Alexander A Perakis, Celine Kerros, et al.JAMA Oncology|April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and PertuzumabAdrienne G Waks, Esther R Ogayo, Laia Paré, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast CancerTanya E Keenan, Tianyu Li, Tuulia Vallius, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2024
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast CancerStefania Morganti, Christopher J Gibson, Qingchun Jin, et al.Breast Cancer Research and Treatment|April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancerClinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.Biorxiv : the Preprint Server for Biology|December 9, 2024
An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancerKenichi Shimada, Daniel E Michaud, Yvonne Xiaoyong Cui, et al.Pageof 43